Literature DB >> 23576553

Dual role of the antioxidant enzyme peroxiredoxin 6 in skin carcinogenesis.

Frank Rolfs1, Marcel Huber, Florian Gruber, Friederike Böhm, Herbert J Pfister, Valery N Bochkov, Erwin Tschachler, Reinhard Dummer, Daniel Hohl, Matthias Schäfer, Sabine Werner.   

Abstract

The antioxidant enzyme peroxiredoxin 6 (Prdx6) is a key regulator of the cellular redox balance, particularly under stress conditions. We identified Prdx6 as an important player in different phases of skin carcinogenesis. Loss of Prdx6 in mice enhanced the susceptibility to skin tumorigenesis, whereas overexpression of Prdx6 in keratinocytes of transgenic mice had the opposite effect. The tumor-preventive effect of Prdx6, which was observed in a human papilloma virus 8-induced and a chemically induced tumor model, was not due to alterations in keratinocyte proliferation, apoptosis, or in the inflammatory response. Rather, endogenous and overexpressed Prdx6 reduced oxidative stress as reflected by the lower levels of oxidized phospholipids in the protumorigenic skin of Prdx6 transgenic mice and the higher levels in Prdx6-knockout mice than in control animals. In contrast to its beneficial effect in tumor prevention, overexpression of Prdx6 led to an acceleration of malignant progression of existing tumors, revealing a dual function of this enzyme in the pathogenesis of skin cancer. Finally, we found strong expression of PRDX6 in keratinocytes of normal human skin and in the tumor cells of squamous cell carcinomas, indicating a role of Prdx6 in human skin carcinogenesis. Taken together, our data point to the potential usefulness of Prdx6 activators or inhibitors for controlling different stages of skin carcinogenesis. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23576553     DOI: 10.1158/0008-5472.CAN-12-4369

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Checkpoint kinase 1 inhibitors as targeted molecular agents for clear cell carcinoma of the ovary.

Authors:  Hiroshi Kobayashi; Hiroshi Shigetomi; Chiharu Yoshimoto
Journal:  Oncol Lett       Date:  2015-05-26       Impact factor: 2.967

2.  Proteome-wide detection and quantitative analysis of irreversible cysteine oxidation using long column UPLC-pSRM.

Authors:  Chia-Fang Lee; Tanya T Paull; Maria D Person
Journal:  J Proteome Res       Date:  2013-09-06       Impact factor: 4.466

Review 3.  The phospholipase A2 activity of peroxiredoxin 6.

Authors:  Aron B Fisher
Journal:  J Lipid Res       Date:  2018-05-01       Impact factor: 5.922

Review 4.  The Roles of Peroxiredoxin 6 in Brain Diseases.

Authors:  Jiangfeng Liao; Yusi Zhang; Xiaochun Chen; Jing Zhang
Journal:  Mol Neurobiol       Date:  2021-05-19       Impact factor: 5.590

Review 5.  Oxidative stress in aging human skin.

Authors:  Mark Rinnerthaler; Johannes Bischof; Maria Karolin Streubel; Andrea Trost; Klaus Richter
Journal:  Biomolecules       Date:  2015-04-21

6.  Acetaminophen-induced liver damage in mice is associated with gender-specific adduction of peroxiredoxin-6.

Authors:  Isaac Mohar; Brendan D Stamper; Peter M Rademacher; Collin C White; Sidney D Nelson; Terrance J Kavanagh
Journal:  Redox Biol       Date:  2014-01-20       Impact factor: 11.799

7.  Peroxiredoxin 6 in skin carcinogenesis.

Authors:  Frank Rolfs; Matthias Schäfer; Sabine Werner
Journal:  Oncoscience       Date:  2014-05-21

8.  Involvement of a 1-Cys peroxiredoxin in bacterial virulence.

Authors:  Gilberto Hideo Kaihami; José Roberto Fogaça de Almeida; Suelen Silvana dos Santos; Luis Eduardo Soares Netto; Sandro Rogério de Almeida; Regina Lúcia Baldini
Journal:  PLoS Pathog       Date:  2014-10-16       Impact factor: 6.823

9.  Functional screening implicates miR-371-3p and peroxiredoxin 6 in reversible tolerance to cancer drugs.

Authors:  Nisebita Sahu; Jean-Philippe Stephan; Darlene Dela Cruz; Mark Merchant; Benjamin Haley; Richard Bourgon; Marie Classon; Jeff Settleman
Journal:  Nat Commun       Date:  2016-08-03       Impact factor: 14.919

10.  Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma.

Authors:  Yajun Shen; Haoyue Xu; Lingyu Li; Yunping Lu; Min Zhang; Xin Huang; Xiaofei Tang
Journal:  Cancer Manag Res       Date:  2021-07-15       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.